nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP4F2—tongue—hypothyroidism	0.0478	0.0752	CbGeAlD
Fingolimod—S1PR4—heart—hypothyroidism	0.0231	0.0363	CbGeAlD
Fingolimod—S1PR4—adrenal gland—hypothyroidism	0.0172	0.0271	CbGeAlD
Fingolimod—S1PR4—blood—hypothyroidism	0.0172	0.0271	CbGeAlD
Fingolimod—S1PR4—thyroid gland—hypothyroidism	0.0166	0.0261	CbGeAlD
Fingolimod—S1PR3—heart—hypothyroidism	0.0161	0.0253	CbGeAlD
Fingolimod—S1PR3—cardiovascular system—hypothyroidism	0.0152	0.0239	CbGeAlD
Fingolimod—S1PR5—adrenal gland—hypothyroidism	0.0145	0.0228	CbGeAlD
Fingolimod—S1PR5—blood—hypothyroidism	0.0145	0.0228	CbGeAlD
Fingolimod—S1PR1—heart—hypothyroidism	0.0142	0.0223	CbGeAlD
Fingolimod—SPHK1—heart—hypothyroidism	0.0141	0.0221	CbGeAlD
Fingolimod—CYP4F12—adrenal cortex—hypothyroidism	0.014	0.022	CbGeAlD
Fingolimod—S1PR3—gonad—hypothyroidism	0.0138	0.0217	CbGeAlD
Fingolimod—CYP4F2—blood—hypothyroidism	0.0136	0.0213	CbGeAlD
Fingolimod—CYP4F12—heart—hypothyroidism	0.0135	0.0212	CbGeAlD
Fingolimod—S1PR1—cardiovascular system—hypothyroidism	0.0134	0.0211	CbGeAlD
Fingolimod—SPHK1—cardiovascular system—hypothyroidism	0.0133	0.0209	CbGeAlD
Fingolimod—SPHK1—gonad—hypothyroidism	0.012	0.0189	CbGeAlD
Fingolimod—S1PR3—adrenal gland—hypothyroidism	0.012	0.0189	CbGeAlD
Fingolimod—SPHK1—pituitary gland—hypothyroidism	0.0117	0.0185	CbGeAlD
Fingolimod—S1PR3—thyroid gland—hypothyroidism	0.0116	0.0183	CbGeAlD
Fingolimod—S1PR5—liver—hypothyroidism	0.0113	0.0178	CbGeAlD
Fingolimod—CYP4F12—pituitary gland—hypothyroidism	0.0113	0.0177	CbGeAlD
Fingolimod—S1PR3—female gonad—hypothyroidism	0.0112	0.0176	CbGeAlD
Fingolimod—S1PR5—cerebellum—hypothyroidism	0.0111	0.0174	CbGeAlD
Fingolimod—S1PR1—adrenal gland—hypothyroidism	0.0106	0.0167	CbGeAlD
Fingolimod—CYP4F2—liver—hypothyroidism	0.0106	0.0167	CbGeAlD
Fingolimod—S1PR1—blood—hypothyroidism	0.0106	0.0167	CbGeAlD
Fingolimod—SPHK1—adrenal gland—hypothyroidism	0.0105	0.0165	CbGeAlD
Fingolimod—SPHK1—blood—hypothyroidism	0.0105	0.0165	CbGeAlD
Fingolimod—S1PR1—thyroid gland—hypothyroidism	0.0102	0.0161	CbGeAlD
Fingolimod—SPHK1—thyroid gland—hypothyroidism	0.0101	0.0159	CbGeAlD
Fingolimod—CYP4F12—adrenal gland—hypothyroidism	0.0101	0.0159	CbGeAlD
Fingolimod—CYP4F12—blood—hypothyroidism	0.0101	0.0158	CbGeAlD
Fingolimod—S1PR3—testis—hypothyroidism	0.00995	0.0156	CbGeAlD
Fingolimod—S1PR1—female gonad—hypothyroidism	0.00989	0.0155	CbGeAlD
Fingolimod—SPHK1—female gonad—hypothyroidism	0.00978	0.0154	CbGeAlD
Fingolimod—CYP4F12—thyroid gland—hypothyroidism	0.00973	0.0153	CbGeAlD
Fingolimod—S1PR3—liver—hypothyroidism	0.00941	0.0148	CbGeAlD
Fingolimod—CYP4F12—female gonad—hypothyroidism	0.0094	0.0148	CbGeAlD
Fingolimod—CYP2E1—urine—hypothyroidism	0.00889	0.014	CbGeAlD
Fingolimod—S1PR1—testis—hypothyroidism	0.00877	0.0138	CbGeAlD
Fingolimod—SPHK1—testis—hypothyroidism	0.00868	0.0136	CbGeAlD
Fingolimod—CYP4F12—testis—hypothyroidism	0.00834	0.0131	CbGeAlD
Fingolimod—S1PR1—liver—hypothyroidism	0.00829	0.013	CbGeAlD
Fingolimod—S1PR1—cerebellum—hypothyroidism	0.0081	0.0127	CbGeAlD
Fingolimod—CYP4F12—liver—hypothyroidism	0.00788	0.0124	CbGeAlD
Fingolimod—CYP4F12—cerebellum—hypothyroidism	0.0077	0.0121	CbGeAlD
Fingolimod—CYP3A4—urine—hypothyroidism	0.00715	0.0112	CbGeAlD
Fingolimod—CYP2D6—urine—hypothyroidism	0.00704	0.0111	CbGeAlD
Fingolimod—CYP4F12—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00565	0.0212	CbGpPWpGaD
Fingolimod—Hypertension—Liothyronine—hypothyroidism	0.00532	0.0548	CcSEcCtD
Fingolimod—CYP4F2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00488	0.0183	CbGpPWpGaD
Fingolimod—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00478	0.0492	CcSEcCtD
Fingolimod—Cardiac arrest—Levothyroxine—hypothyroidism	0.00478	0.0492	CcSEcCtD
Fingolimod—Hypotension—Liothyronine—hypothyroidism	0.0047	0.0484	CcSEcCtD
Fingolimod—CYP4F12—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00458	0.0172	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00414	0.0155	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.00412	0.0154	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00398	0.0149	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00398	0.0149	CbGpPWpGaD
Fingolimod—CYP4F2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00395	0.0148	CbGpPWpGaD
Fingolimod—Weight decreased—Dextrothyroxine—hypothyroidism	0.00393	0.0405	CcSEcCtD
Fingolimod—Weight decreased—Levothyroxine—hypothyroidism	0.00393	0.0405	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—VAV3—hypothyroidism	0.00389	0.0146	CbGpPWpGaD
Fingolimod—Cerebrovascular accident—Liotrix—hypothyroidism	0.00377	0.0389	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00369	0.0138	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00369	0.0138	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00362	0.0135	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00355	0.0133	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00355	0.0133	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00355	0.0133	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00355	0.0133	CbGpPWpGaD
Fingolimod—Cardiac arrest—Liotrix—hypothyroidism	0.00351	0.0362	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00322	0.0121	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00322	0.0121	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—TRH—hypothyroidism	0.00315	0.0118	CbGpPWpGaD
Fingolimod—Bronchitis—Liotrix—hypothyroidism	0.00307	0.0316	CcSEcCtD
Fingolimod—Alopecia—Levothyroxine—hypothyroidism	0.00307	0.0316	CcSEcCtD
Fingolimod—Alopecia—Dextrothyroxine—hypothyroidism	0.00307	0.0316	CcSEcCtD
Fingolimod—S1PR3—GPCR ligand binding—TRH—hypothyroidism	0.00303	0.0114	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—TRH—hypothyroidism	0.00303	0.0114	CbGpPWpGaD
Fingolimod—Weight decreased—Liotrix—hypothyroidism	0.00289	0.0298	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—IYD—hypothyroidism	0.00287	0.0107	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—TSHB—hypothyroidism	0.00281	0.0105	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—TSHR—hypothyroidism	0.00281	0.0105	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—TRH—hypothyroidism	0.00275	0.0103	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—TSHB—hypothyroidism	0.0027	0.0101	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—TSHR—hypothyroidism	0.0027	0.0101	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—TSHB—hypothyroidism	0.0027	0.0101	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—TSHR—hypothyroidism	0.0027	0.0101	CbGpPWpGaD
Fingolimod—Palpitations—Levothyroxine—hypothyroidism	0.00267	0.0275	CcSEcCtD
Fingolimod—Palpitations—Dextrothyroxine—hypothyroidism	0.00267	0.0275	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—IYD—hypothyroidism	0.00248	0.00928	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—TSHR—hypothyroidism	0.00245	0.00919	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—TSHB—hypothyroidism	0.00245	0.00919	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ATP5O—hypothyroidism	0.00244	0.00914	CbGpPWpGaD
Fingolimod—CYP4F12—Biological oxidations—POMC—hypothyroidism	0.00243	0.00911	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—TPO—hypothyroidism	0.00229	0.00859	CbGpPWpGaD
Fingolimod—Alopecia—Liotrix—hypothyroidism	0.00226	0.0233	CcSEcCtD
Fingolimod—Dyspnoea—Dextrothyroxine—hypothyroidism	0.0022	0.0227	CcSEcCtD
Fingolimod—Dyspnoea—Levothyroxine—hypothyroidism	0.0022	0.0227	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00217	0.00814	CbGpPWpGaD
Fingolimod—CYP2E1—cardiovascular system—hypothyroidism	0.00215	0.00338	CbGeAlD
Fingolimod—Fatigue—Dextrothyroxine—hypothyroidism	0.00213	0.0219	CcSEcCtD
Fingolimod—Fatigue—Levothyroxine—hypothyroidism	0.00213	0.0219	CcSEcCtD
Fingolimod—SPHK1—Metabolism—IYD—hypothyroidism	0.00213	0.00797	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ATP5O—hypothyroidism	0.00211	0.00789	CbGpPWpGaD
Fingolimod—CYP4F2—Biological oxidations—POMC—hypothyroidism	0.0021	0.00786	CbGpPWpGaD
Fingolimod—Vision blurred—Liotrix—hypothyroidism	0.0021	0.0216	CcSEcCtD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00209	0.00784	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00209	0.00784	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—TPO—hypothyroidism	0.00198	0.00742	CbGpPWpGaD
Fingolimod—Palpitations—Liotrix—hypothyroidism	0.00197	0.0203	CcSEcCtD
Fingolimod—Hypertension—Liotrix—hypothyroidism	0.00192	0.0198	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.0019	0.00712	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00183	0.00687	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—POMC—hypothyroidism	0.00182	0.0068	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ATP5O—hypothyroidism	0.00181	0.00678	CbGpPWpGaD
Fingolimod—Infection—Liotrix—hypothyroidism	0.0018	0.0186	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—TRH—hypothyroidism	0.00178	0.00667	CbGpPWpGaD
Fingolimod—Asthenia—Dextrothyroxine—hypothyroidism	0.00177	0.0183	CcSEcCtD
Fingolimod—Asthenia—Levothyroxine—hypothyroidism	0.00177	0.0183	CcSEcCtD
Fingolimod—S1PR3—G alpha (i) signalling events—POMC—hypothyroidism	0.00175	0.00655	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—POMC—hypothyroidism	0.00175	0.00655	CbGpPWpGaD
Fingolimod—Pruritus—Levothyroxine—hypothyroidism	0.00175	0.018	CcSEcCtD
Fingolimod—Pruritus—Dextrothyroxine—hypothyroidism	0.00175	0.018	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—TRH—hypothyroidism	0.00171	0.00642	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—TRH—hypothyroidism	0.00171	0.00642	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TPO—hypothyroidism	0.0017	0.00637	CbGpPWpGaD
Fingolimod—CYP2E1—adrenal gland—hypothyroidism	0.0017	0.00267	CbGeAlD
Fingolimod—CYP2E1—blood—hypothyroidism	0.0017	0.00267	CbGeAlD
Fingolimod—Hypotension—Liotrix—hypothyroidism	0.0017	0.0175	CcSEcCtD
Fingolimod—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00169	0.0174	CcSEcCtD
Fingolimod—Diarrhoea—Levothyroxine—hypothyroidism	0.00169	0.0174	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—AVP—hypothyroidism	0.00166	0.0062	CbGpPWpGaD
Fingolimod—CYP2E1—thyroid gland—hypothyroidism	0.00164	0.00258	CbGeAlD
Fingolimod—Paraesthesia—Liotrix—hypothyroidism	0.00163	0.0168	CcSEcCtD
Fingolimod—Dyspnoea—Liotrix—hypothyroidism	0.00162	0.0167	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—TRH—hypothyroidism	0.00162	0.00606	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—AVP—hypothyroidism	0.00159	0.00597	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—AVP—hypothyroidism	0.00159	0.00597	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—POMC—hypothyroidism	0.00159	0.00595	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—TSHB—hypothyroidism	0.00159	0.00594	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—TSHR—hypothyroidism	0.00159	0.00594	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00158	0.0059	CbGpPWpGaD
Fingolimod—Fatigue—Liotrix—hypothyroidism	0.00157	0.0161	CcSEcCtD
Fingolimod—S1PR5—Signaling by GPCR—TRH—hypothyroidism	0.00156	0.00583	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TRH—hypothyroidism	0.00156	0.00583	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TRH—hypothyroidism	0.00156	0.00583	CbGpPWpGaD
Fingolimod—Headache—Levothyroxine—hypothyroidism	0.00155	0.0159	CcSEcCtD
Fingolimod—Headache—Dextrothyroxine—hypothyroidism	0.00155	0.0159	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—TSHB—hypothyroidism	0.00153	0.00572	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—TSHB—hypothyroidism	0.00153	0.00572	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—TSHB—hypothyroidism	0.00153	0.00572	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—TSHR—hypothyroidism	0.00153	0.00572	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—TSHR—hypothyroidism	0.00153	0.00572	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—AVP—hypothyroidism	0.00145	0.00542	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00144	0.00541	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—TSHB—hypothyroidism	0.00144	0.0054	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—TSHR—hypothyroidism	0.00144	0.0054	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TRH—hypothyroidism	0.00141	0.00529	CbGpPWpGaD
Fingolimod—CYP2E1—testis—hypothyroidism	0.00141	0.00221	CbGeAlD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00139	0.00521	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00139	0.00521	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TSHB—hypothyroidism	0.00139	0.0052	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—TSHB—hypothyroidism	0.00139	0.0052	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TSHR—hypothyroidism	0.00139	0.0052	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—TSHR—hypothyroidism	0.00139	0.0052	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TSHB—hypothyroidism	0.00139	0.0052	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TSHR—hypothyroidism	0.00139	0.0052	CbGpPWpGaD
Fingolimod—CYP3A4—blood—hypothyroidism	0.00137	0.00215	CbGeAlD
Fingolimod—CYP2D6—blood—hypothyroidism	0.00135	0.00212	CbGeAlD
Fingolimod—CYP2E1—liver—hypothyroidism	0.00133	0.00209	CbGeAlD
Fingolimod—Asthenia—Liotrix—hypothyroidism	0.0013	0.0134	CcSEcCtD
Fingolimod—CYP2E1—cerebellum—hypothyroidism	0.0013	0.00204	CbGeAlD
Fingolimod—Pruritus—Liotrix—hypothyroidism	0.00128	0.0132	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00126	0.00473	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TSHB—hypothyroidism	0.00126	0.00472	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TSHR—hypothyroidism	0.00126	0.00472	CbGpPWpGaD
Fingolimod—CYP2D6—female gonad—hypothyroidism	0.00126	0.00197	CbGeAlD
Fingolimod—Diarrhoea—Liotrix—hypothyroidism	0.00124	0.0128	CcSEcCtD
Fingolimod—Dizziness—Liotrix—hypothyroidism	0.0012	0.0124	CcSEcCtD
Fingolimod—Headache—Liotrix—hypothyroidism	0.00114	0.0117	CcSEcCtD
Fingolimod—CYP2D6—testis—hypothyroidism	0.00111	0.00175	CbGeAlD
Fingolimod—S1PR4—Signaling Pathways—CLTC—hypothyroidism	0.00111	0.00414	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—POMC—hypothyroidism	0.0011	0.00412	CbGpPWpGaD
Fingolimod—CYP3A4—liver—hypothyroidism	0.00107	0.00168	CbGeAlD
Fingolimod—S1PR5—Signaling Pathways—CLTC—hypothyroidism	0.00106	0.00399	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CLTC—hypothyroidism	0.00106	0.00399	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—TSHB—hypothyroidism	0.00106	0.00398	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—POMC—hypothyroidism	0.00106	0.00397	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—POMC—hypothyroidism	0.00106	0.00397	CbGpPWpGaD
Fingolimod—CYP2D6—liver—hypothyroidism	0.00105	0.00165	CbGeAlD
Fingolimod—CYP2D6—cerebellum—hypothyroidism	0.00103	0.00162	CbGeAlD
Fingolimod—S1PR4—GPCR downstream signaling—VAV3—hypothyroidism	0.000971	0.00364	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CLTC—hypothyroidism	0.000966	0.00362	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—POMC—hypothyroidism	0.000961	0.0036	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TRH—hypothyroidism	0.000955	0.00358	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3C2A—hypothyroidism	0.000947	0.00355	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AVP—hypothyroidism	0.000935	0.0035	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—VAV3—hypothyroidism	0.000935	0.0035	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—VAV3—hypothyroidism	0.000935	0.0035	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TRH—hypothyroidism	0.000919	0.00344	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TRH—hypothyroidism	0.000919	0.00344	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—TSHB—hypothyroidism	0.000917	0.00343	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AVP—hypothyroidism	0.0009	0.00337	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AVP—hypothyroidism	0.0009	0.00337	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—VAV3—hypothyroidism	0.000882	0.0033	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CLTC—hypothyroidism	0.000855	0.0032	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TSHR—hypothyroidism	0.000851	0.00319	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TSHB—hypothyroidism	0.000851	0.00319	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AVP—hypothyroidism	0.000849	0.00318	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—VAV3—hypothyroidism	0.000849	0.00318	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—VAV3—hypothyroidism	0.000849	0.00318	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—VAV3—hypothyroidism	0.000849	0.00318	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TRH—hypothyroidism	0.000835	0.00313	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TSHB—hypothyroidism	0.00082	0.00307	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TSHB—hypothyroidism	0.00082	0.00307	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TSHR—hypothyroidism	0.00082	0.00307	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TSHR—hypothyroidism	0.00082	0.00307	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AVP—hypothyroidism	0.000818	0.00306	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AVP—hypothyroidism	0.000818	0.00306	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AVP—hypothyroidism	0.000818	0.00306	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3C2A—hypothyroidism	0.000817	0.00306	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000806	0.00302	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—SLC5A5—hypothyroidism	0.000795	0.00298	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TSHB—hypothyroidism	0.000788	0.00295	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—VAV3—hypothyroidism	0.000771	0.00289	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SH2B3—hypothyroidism	0.000759	0.00284	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TSHB—hypothyroidism	0.000744	0.00279	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TSHR—hypothyroidism	0.000744	0.00279	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AVP—hypothyroidism	0.000742	0.00278	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TRH—hypothyroidism	0.000739	0.00277	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SH2B3—hypothyroidism	0.00073	0.00274	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SH2B3—hypothyroidism	0.00073	0.00274	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3C2A—hypothyroidism	0.000702	0.00263	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000693	0.00259	CbGpPWpGaD
Fingolimod—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000688	0.00258	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—SLC5A5—hypothyroidism	0.000686	0.00257	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SH2B3—hypothyroidism	0.000663	0.00248	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TSHB—hypothyroidism	0.000659	0.00247	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TSHR—hypothyroidism	0.000659	0.00247	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—POMC—hypothyroidism	0.000622	0.00233	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—POMC—hypothyroidism	0.000599	0.00224	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—POMC—hypothyroidism	0.000598	0.00224	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—POMC—hypothyroidism	0.000598	0.00224	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—SLC5A5—hypothyroidism	0.00059	0.00221	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SH2B3—hypothyroidism	0.000587	0.0022	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—IGF1—hypothyroidism	0.000576	0.00216	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—POMC—hypothyroidism	0.000564	0.00211	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PRL—hypothyroidism	0.000563	0.00211	CbGpPWpGaD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000557	0.00209	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—POMC—hypothyroidism	0.000543	0.00204	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—POMC—hypothyroidism	0.000543	0.00204	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—POMC—hypothyroidism	0.000543	0.00204	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PRL—hypothyroidism	0.000542	0.00203	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PRL—hypothyroidism	0.000542	0.00203	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VAV3—hypothyroidism	0.000521	0.00195	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AVP—hypothyroidism	0.000502	0.00188	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VAV3—hypothyroidism	0.000501	0.00188	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VAV3—hypothyroidism	0.000501	0.00188	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—POMC—hypothyroidism	0.000493	0.00185	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PRL—hypothyroidism	0.000492	0.00184	CbGpPWpGaD
Fingolimod—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000488	0.00183	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AVP—hypothyroidism	0.000483	0.00181	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AVP—hypothyroidism	0.000483	0.00181	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VAV3—hypothyroidism	0.000455	0.00171	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AVP—hypothyroidism	0.000439	0.00164	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PRL—hypothyroidism	0.000435	0.00163	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—POMC—hypothyroidism	0.000416	0.00156	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VAV3—hypothyroidism	0.000403	0.00151	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000396	0.00148	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AVP—hypothyroidism	0.000388	0.00145	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—POMC—hypothyroidism	0.000359	0.00134	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—IYD—hypothyroidism	0.000349	0.00131	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—POMC—hypothyroidism	0.000333	0.00125	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—POMC—hypothyroidism	0.000321	0.0012	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—POMC—hypothyroidism	0.000321	0.0012	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF1—hypothyroidism	0.000321	0.0012	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000319	0.0012	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF1—hypothyroidism	0.000309	0.00116	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1—hypothyroidism	0.000309	0.00116	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—POMC—hypothyroidism	0.000308	0.00116	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ATP5O—hypothyroidism	0.000297	0.00111	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—POMC—hypothyroidism	0.000296	0.00111	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—POMC—hypothyroidism	0.000291	0.00109	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1—hypothyroidism	0.00028	0.00105	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TPO—hypothyroidism	0.000279	0.00105	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000259	0.000969	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—POMC—hypothyroidism	0.000258	0.000966	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1—hypothyroidism	0.000248	0.000929	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—IYD—hypothyroidism	0.000248	0.000929	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000211	0.00079	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.00021	0.000787	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TPO—hypothyroidism	0.000198	0.000742	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—IYD—hypothyroidism	0.000162	0.000607	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000138	0.000516	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000137	0.000515	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TPO—hypothyroidism	0.00013	0.000485	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TSHB—hypothyroidism	0.000129	0.000484	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	0.000115	0.000432	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A5—hypothyroidism	9.68e-05	0.000363	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TSHB—hypothyroidism	9.18e-05	0.000344	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	8.18e-05	0.000306	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A5—hypothyroidism	6.87e-05	0.000257	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TSHB—hypothyroidism	6e-05	0.000225	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	5.35e-05	0.0002	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—POMC—hypothyroidism	5.06e-05	0.00019	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A5—hypothyroidism	4.49e-05	0.000168	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—POMC—hypothyroidism	3.59e-05	0.000135	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—POMC—hypothyroidism	2.35e-05	8.8e-05	CbGpPWpGaD
